Skip to main content

Table 2 Comparison of Clinical Data between the AMI Group & stable CAD Group

From: Low expression of PRMT5 in peripheral blood may serve as a potential independent risk factor in assessments of the risk of stable CAD and AMI

Categories of Data The AMI Group The stable CAD Group t/x2/z P Value
N = 91 N = 87   
Age (years old) 63.51 ± 10.506 61.9 ± 9.077 1.095 0.275
Sex    1.185 0.276
 Male 59(64.8%) 63(72.4%)   
 Female 32(35.2%) 24(27.6%)   
BMI (Kg/m2) 24.728(22.477–27.357) 25.626 ± 3.188 −1.711 0.087
Hypertension 46(50.5%) 44(50.6%) 0.000 0.997
Family Medical History 7(7.7%) 4(4.6%) 0.718 0.397
Systolic Pressure (mmHg) 135.08 ± 24.740 136.38 ± 20.213 −0.350 0.727
Diastolic Pressure (mmHg) 81(75.750–91) 81.07 ± 12.472 −1.136 0.256
Smoking History 42(46.2%) 43(49.4%) 0.191 0.662
Diabetes 24(26.4%) 24(27.6%) 0.033 0.855
Fasting Blood-glucose (mmol/l) 6.03(5.085–8.235) 5.81(5.240–8.170) −0.356 0.722
TG (mmol/l) 1.57(1.16–2.303) 1.74(1.14–2.5) −0.856 0.392
HDL-C (mmol/l) 0.96(0.085–1.133) 0.88(0.770–1.070) −1.901 0.057
TC (mmol/l) 4.616 ± 1.300 4.213 ± 1.048 2.233 0.027
LDL-C (mmol/l) 3.136 ± 1.047 2.770 ± 0.877 2.480 0.014
EF(%) 63(42–65) 65(63–67.25) −3.482 0.000
Aspirin 87(95.6%) 85(97.7%) −0.773 0.440
Clopidogrel 78(85.7%) 77(88.5%) −0.553 0.580
Ticagrelor 1(1.1%) 2(2.3%) −0.620 0.535
Beta blockers 55(60.4%) 45(51.7%) −1.168 0.243
CCB 25(27.5%) 27(31.0%) −0.521 0.602
ACE-I or ARB 47(51.6%) 30(34.5%) −2.304 0.021
Statin 73(80.2%) 75(86.2%) −1.064 0.287
PCI 76(83.5%) 53(60.9%) −2.593 0.010
\